PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

EVALUATION OF TREATMENT RESULTS IN PATIENTS WITH PEYRONIE'S DISEASE TREATED WITH LOCAL INJECTION OF ORGOTEIN
Article published in Urologia Polska 1995/48/3.

authors

Janusz Darewicz, Tadeusz Werel, Barbara Darewicz, Lech Gałek
Z Kliniki Urologii Akademii Medycznej w Białymstoku
Kierownik Kliniki: doc. dr hab. med. J. Darewicz

summary

The authors present 16 men with Peyronie's disease treated with local injection of Orgotein. In 14
patients there was general improvement, decrease or reliefe of pain during intercourse, reduction or
disappearance of penile curvature and erectile improvement in 2. In 8 patients we found pla±ue
dimameter to be diminished. Authors believe that Orgotein is one of the most effective drugs in
conservative treatment of Peyronie's disease.

references

  1. 1. Bartsch C, Menander-Huber K.K., Huber W., Marberger H:. Orgotein, a new drug for the
  2. treatment of Peyronie's disease. Eur.J. Rheumatol. Inflamm., 1981,4,3, 250. ? 2. Chilton C.P.,
  3. Castle W.M., Westwood CA., Pryor J.P.: Factors associated in the aetiology of Peyronie's disease.
  4. Brit. J. Urol., 1982, 54, 6, 748. ? 3. Devine Jr. C.J., Horton C.E.: Peyronie's disease. Clin. Piast.
  5. Surg., 1988,15, 3, 405. ? 4. Gustafson H., Johansson B., Edsmyr F.: Peyronie's disease: experien-
  6. ce of local treatment with Orgotein. Eur. Urol., 1981, 7, 4, 346. ? 5. Horton C.E., Sadove R.C.,
  7. DevineJr. C.J.: Peyronie's disease. Ann. Piast. Surg., 1987, 18,2, 121. ? 6. Huber W., Schulte T.L.,
  8. Carson S., Goidhammerr R.E., Vogin E.E.: Some chemical and pharmacological properties of a
  9. novel anti- inflammatory protein. Toxicol. Appl. Pharmacol., 1968, 12, 4, 308. ? 7. Jeromin L,
  10. Lipiński M: Próba leczenia choroby Peyronie orgotein±. Urol. Pol., 1986, 39, 1,7 ? 8. Leńko J.\
  11. Choroba Peyronie- zagadnienie lecznicze. Urol. Pol, 1979; 32, 2, 105. ? 9. Marberger H, Huber
  12. W., Bartsch G., Schulte T., Swoboda P.: Orgotein a new antiinflammatory metalprotein drug. Evalu-
  13. ation of clinical effeciacy and safety in inflammatory conditions of the urinary tract. J. Urol. Neph-
  14. rol., 1974, 6, 1,61. ? 10. Morales A., Bruce A.W.: The treatment of Peyronie's disease with parathy-
  15. roid hormone. J. Urol.,1975, 114, 6, 901. ? 11. Morgan R.J., Pryor J.P.: Procarbazine (Natulan) in
  16. the treatment of Peyronie's disease. Brit. J. Urol., 1978, 50, 2, 111. ? 12. Ralph D.J., Brooks M.D.,
  17. Bottazzo G.F., Pryor J.P.: The treatment of Peyronie's disease with Tamoxifen. Brit. J. Urol., 1992,
  18. 70, 6, 648 ? 13. Scardino P.L., Scott W.W., Ant M.: The use of Tocoferols in the treatment of
  19. Peyronie s disease. Ann. N.Y. Acad. Sci., 1949, 52, 4, 390. ? 14. Scheinman L.J., Miller E.V.: Use
  20. of dimethylsulfoxide (DMSO) in Peyronie's disease; a preliminary report. Pacif. Med. Surg., 1967,
  21. 75, 1, 61. ? 15. Zarafonetis C.J.D., Horrax T.M.: Treatment of Peyronie's disease with Potassium
  22. Paraaminobenzoate (Potaba). J. Urol.,1959, 81, 6, 770.